Interferons in the treatment of skin disease.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D005260:Female; D006561:Herpes Simplex / Q000628:therapy; D006562:Herpes Zoster / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008223:Lymphoma / Q000628:therapy; D008297:Male; D008545:Melanoma / Q000628:therapy; D009182:Mycosis Fungoides / Q000150:complications / Q000628:therapy; D027383:Papillomaviridae; D011565:Psoriasis / Q000628:therapy; D012514:Sarcoma, Kaposi / Q000628:therapy; D012751:Sezary Syndrome / Q000628:therapy; D012871:Skin Diseases / Q000628:therapy*; D012874:Skin Diseases, Infectious / Q000628:therapy; D012878:Skin Neoplasms / Q000628:therapy; D013601:T-Lymphocytes; D013997:Time Factors; D014412:Tumor Virus Infections / Q000628:therapy
D007370:Interferon Type I; D007372:Interferons